Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$0.82 - $1.35 $410 - $675
-500 Reduced 3.44%
14,054 $12,000
Q4 2023

Feb 09, 2024

BUY
$0.66 - $0.91 $4,478 - $6,174
6,785 Added 87.33%
14,554 $12,000
Q3 2023

Nov 03, 2023

SELL
$0.85 - $1.43 $30,175 - $50,765
-35,500 Reduced 82.04%
7,769 $7,000
Q2 2023

Aug 09, 2023

SELL
$1.12 - $1.49 $1,385 - $1,843
-1,237 Reduced 2.78%
43,269 $51,000
Q4 2022

Feb 13, 2023

BUY
$1.07 - $1.34 $999 - $1,251
934 Added 2.14%
44,506 $53,000
Q3 2022

Oct 27, 2022

BUY
$1.09 - $1.67 $410 - $629
377 Added 0.87%
43,572 $47,000
Q2 2022

Aug 01, 2022

BUY
$1.13 - $3.69 $565 - $1,845
500 Added 1.17%
43,195 $64,000
Q1 2022

May 11, 2022

BUY
$2.85 - $3.73 $1,573 - $2,058
552 Added 1.31%
42,695 $140,000
Q4 2021

Feb 11, 2022

SELL
$3.24 - $5.18 $8,650 - $13,830
-2,670 Reduced 5.96%
42,143 $142,000
Q3 2021

Nov 10, 2021

BUY
$3.94 - $5.84 $6,564 - $9,729
1,666 Added 3.86%
44,813 $228,000
Q2 2021

Aug 05, 2021

SELL
$4.26 - $6.5 $1,393 - $2,125
-327 Reduced 0.75%
43,147 $189,000
Q1 2021

Apr 28, 2021

SELL
$5.03 - $8.8 $5,201 - $9,099
-1,034 Reduced 2.32%
43,474 $270,000
Q4 2020

Feb 04, 2021

BUY
$4.04 - $5.31 $7,482 - $9,834
1,852 Added 4.34%
44,508 $217,000
Q3 2020

Nov 10, 2020

BUY
$3.64 - $7.76 $20,205 - $43,075
5,551 Added 14.96%
42,656 $180,000
Q2 2020

Aug 07, 2020

BUY
$4.78 - $8.26 $16,457 - $28,439
3,443 Added 10.23%
37,105 $256,000
Q1 2020

May 13, 2020

BUY
$4.0 - $21.53 $50,704 - $272,914
12,676 Added 60.4%
33,662 $135,000
Q4 2019

Feb 04, 2020

BUY
$13.94 - $24.12 $209,100 - $361,800
15,000 Added 250.58%
20,986 $450,000
Q3 2019

Nov 08, 2019

SELL
$13.89 - $23.16 $3,375 - $5,627
-243 Reduced 3.9%
5,986 $90,000
Q2 2019

Aug 13, 2019

BUY
$16.27 - $20.51 $13,959 - $17,597
858 Added 15.97%
6,229 $121,000
Q1 2019

May 08, 2019

BUY
$12.61 - $22.33 $15,964 - $28,269
1,266 Added 30.84%
5,371 $111,000
Q4 2018

Feb 13, 2019

BUY
$12.41 - $22.98 $27,302 - $50,556
2,200 Added 115.49%
4,105 $56,000
Q3 2018

Nov 01, 2018

BUY
$2.45 - $16.27 $73 - $488
30 Added 1.6%
1,905 $31,000
Q2 2018

Aug 08, 2018

BUY
$2.68 - $3.48 $2,345 - $3,045
875 Added 87.5%
1,875 $6,000
Q3 2017

Nov 13, 2017

BUY
$3.03 - $3.72 $3,030 - $3,720
1,000
1,000 $4,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $222M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.